Eli Lilly and Co (LLY)

LLY (NYSE:Drugs) EQUITY
$82.49
pos +0.65
+0.79%
Today's Range: 81.46 - 82.40 | LLY Avg Daily Volume: 3,612,500
Last Update: 07/27/17 - 11:04 AM EDT
Volume: 1,246,321
YTD Performance: 11.27%
Open: $81.76
Previous Close: $81.84
52 Week Range: $64.18 - $86.72
Oustanding Shares: 1,103,388,743
Market Cap: 90,687,520,787
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 10 11
Moderate Buy 1 1 1 1
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.81 1.81 1.81 1.76
Latest Dividend: 0.52
Latest Dividend Yield: 2.53%
Dividend Ex-Date: 08/11/17
Price Earnings Ratio: 35.43
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
35.43 39.70 32.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.09% -0.30% 28.32%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.30 -0.10 -0.03
Net Income 13.70 -0.40 -0.16
EPS 14.20 -0.40 -0.16
Earnings for LLY:
EBITDA 5.34B
Revenue 21.22B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $1.05 $1.04 $4.14 $4.49
Number of Analysts 6 6 10 10
High Estimate $1.11 $1.11 $4.18 $4.66
Low Estimate $0.99 $0.98 $4.10 $4.32
Prior Year $0.88 $0.95 $3.52 $4.14
Growth Rate (Year over Year) 19.70% 9.65% 17.67% 8.33%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Here's What Up (and Down) Real Money Pro($)

After 90 minutes of trading here are some market features:   * Bonds are getting schmeissed. The 10-year U.S. note yield is close to…

Biotech Sees Sharp Reversal Real Money Pro($)

Biotech, as represented by iShares Nasdaq Biotechnology Index Fund (IBB) , universally beloved by technicians and "talking heads" has just suff…
Aratana Therapeutics and Kindred Biosciences are promising drug developers in the pet space.
Days like this remind you why you stay in.
It just isn't as useful or descriptive right now.
A rotation that started as the minor chord of the rotational symphony and is now the major one.
We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.
The handwringers will be out in full force. Their fear creates buying opportunities.
Struggling stock is downgraded.
"There are two kinds of spurs, my friend. Those that come in by the door; those that come in by the window.." -- Tuco, "

Columnist Conversations

Good morning. Futures are up this morning, with the Nasdaq slated to open about 45 points higher. Facebook ($F...
Alliance Data Systems (ADS) announced an expanded and renewed stock buyback this morning. The shares are up f...
we'll take this nice winner off the table SOLD ADSK AUG 105 CALL AT 9 (in at 4.45)

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.